| payload |
{"created_at":"2026-04-22T14:18:39.834 {"created_at":"2026-04-22T14:18:39.834359+00:00","dedupe_key":"signal_enriched:news_delta:0397bbb440615933","evidence_event_ids":["evt_d1b15cefbd81"],"signal_type":"news_headline_delta","source":"news_rss","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPMUV0bGlIT2FTbVZ0d1hQWnZPRFBBbGxjcTJPc1NIWjlzQmhZSnZfQnBJd2FSaDNQS0UxS2J2VXJhby1aRlozRlgtS2Q0UVNlT3BfekR2VjNmTzBqYTJFU0JISTZiYzBuMnRmak5mUzFfbkEzMWRaUFlFcUxMTnZGbXdxdVFqNzV5Y1VYSWprb2Q0TTVEVlZLNWxNU2ROUkkwb0w4eTM0aGlaU1NFRUlLU1BNbw?oc=5","as_of":"2026-04-22T14:18:39.834359+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.ZC4SwnwBFEo.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OnHEEtl37V-jXhbqB2FmnEcwzOBQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPMUV0bGlIT2FTbVZ0d1hQWnZPRFBBbGxjcTJPc1NIWjlzQmhZSnZfQnBJd2FSaDNQS0UxS2J2VXJhby1aRlozRlgtS2Q0UVNlT3BfekR2VjNmTzBqYTJFU0JISTZiYzBuMnRmak5mUzFfbkEzMWRaUFlFcUxMTnZGbXdxdVFqNzV5Y1VYSWprb2Q0TTVEVlZLNWxNU2ROUkkwb0w4eTM0aGlaU1NFRUlLU1BNbw?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_323a96317cf21c16","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.ZC4SwnwBFEo.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OnHEEtl37V-jXhbqB2FmnEcwzOBQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-22T14:21:13.610719+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPMUV0bGlIT2FTbVZ0d1hQWnZPRFBBbGxjcTJPc1NIWjlzQmhZSnZfQnBJd2FSaDNQS0UxS2J2VXJhby1aRlozRlgtS2Q0UVNlT3BfekR2VjNmTzBqYTJFU0JISTZiYzBuMnRmak5mUzFfbkEzMWRaUFlFcUxMTnZGbXdxdVFqNzV5Y1VYSWprb2Q0TTVEVlZLNWxNU2ROUkkwb0w4eTM0aGlaU1NFRUlLU1BNbw?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"drugdiscoverynews.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPMUV0bGlIT2FTbVZ0d1hQWnZPRFBBbGxjcTJPc1NIWjlzQmhZSnZfQnBJd2FSaDNQS0UxS2J2VXJhby1aRlozRlgtS2Q0UVNlT3BfekR2VjNmTzBqYTJFU0JISTZiYzBuMnRmak5mUzFfbkEzMWRaUFlFcUxMTnZGbXdxdVFqNzV5Y1VYSWprb2Q0TTVEVlZLNWxNU2ROUkkwb0w4eTM0aGlaU1NFRUlLU1BNbw?oc=5","source_event_id":"evt_d1b15cefbd81","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"f7f4316d5a84c67c","published_at":"2026-04-22T14:08:27+00:00","publisher_domain":"drugdiscoverynews.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.42,"dates_mentioned":[],"entities":[],"event_type":"other","information_gaps":["article_text_unavailable"],"key_facts":["Headline: Biogen expands control of CD38 antibody felzartamab across global markets - Drug Discovery News","Source summary: Biogen expands control of CD38 antibody felzartamab across global markets Drug Discovery News"],"numeric_claims":[],"primary_claim":"Biogen expands control of CD38 antibody felzartamab across global markets - Drug Discovery News","relevance_score":0.46,"sentiment":"neutral","source_quality":"unknown","summary":"Biogen expands control of CD38 antibody felzartamab across global markets Drug Discovery News","topics":["news headline"]},"source":"Drug Discovery News","source_domain":"drugdiscoverynews.com","source_url":"https://www.drugdiscoverynews.com","summary":"Biogen expands control of CD38 antibody felzartamab across global markets Drug Discovery News","title":"Biogen expands control of CD38 antibody felzartamab across global markets - Drug Discovery News","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.ZC4SwnwBFEo.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OnHEEtl37V-jXhbqB2FmnEcwzOBQ/m=syndicationarticleview,_b,_tp"}}... |